AIMC Topic: Antineoplastic Combined Chemotherapy Protocols

Clear Filters Showing 51 to 60 of 137 articles

H-RACS: a handy tool to rank anti-cancer synergistic drugs.

Aging
Though promising, identifying synergistic combinations from a large pool of candidate drugs remains challenging for cancer treatment. Due to unclear mechanism and limited confirmed cases, only a few computational algorithms are able to predict drug s...

Synergistic drug combinations and machine learning for drug repurposing in chordoma.

Scientific reports
Chordoma is a devastating rare cancer that affects one in a million people. With a mean-survival of just 6 years and no approved medicines, the primary treatments are surgery and radiation. In order to speed new medicines to chordoma patients, a drug...

Robot-assisted combined pancreatectomy/hepatectomy for metastatic pancreatic acinar cell carcinoma: case report and review of the literature.

Clinical journal of gastroenterology
Acinar cell carcinoma (ACC) of the pancreas is a rare neoplasm with less aggressive behavior than ductal carcinoma. As a result, surgical resection for metastatic ACC is a therapeutic option which can result in long-term survival. There is a paucity ...

A machine learning model that classifies breast cancer pathologic complete response on MRI post-neoadjuvant chemotherapy.

Breast cancer research : BCR
BACKGROUND: For breast cancer patients undergoing neoadjuvant chemotherapy (NAC), pathologic complete response (pCR; no invasive or in situ) cannot be assessed non-invasively so all patients undergo surgery. The aim of our study was to develop and va...

Identification of Non-Small Cell Lung Cancer Sensitive to Systemic Cancer Therapies Using Radiomics.

Clinical cancer research : an official journal of the American Association for Cancer Research
PURPOSE: Using standard-of-care CT images obtained from patients with a diagnosis of non-small cell lung cancer (NSCLC), we defined radiomics signatures predicting the sensitivity of tumors to nivolumab, docetaxel, and gefitinib.

Machine Learning for Cancer Drug Combination.

Clinical pharmacology and therapeutics
When treating multiple complex diseases, such as cancer, polytherapy may demonstrate efficiency than monotherapy. However, due to the multiplicative relationship between the number of drugs and cell lines vs. the number of combinations, it is impract...